Cost containment, accelerated time-to-market, recurring revenues and strong cash flows are driving PE interest in the CDMO market.
SNP was founded in 1994 and based in Heidelberg, Germany.
Insights from dealmakers who attended ACG’s DealMax 2025 conference in Las Vegas; an update on companies for sale coverage; thoughts from an industrials-focused investment banker on how the tariff rollercoaster is affecting dealmaking in that sector.
Namirial specializes in software that enables enterprises to verify identities, authenticate signatures and certify transactions.
Michael Blankenship, co-chair of Winston & Strawn’s capital markets practice and Houston managing partner, on take-private deals in private equity this year; the subsector of food-service and why it’s attractive to PE firms; Bain Capital's deal for HealthEdge, a Burlington, Massachusetts-based healthcare tech company.
The company’s product portfolio spans categories such as skin health, foot health, and intimate health, as well as digestive health and vitamins, minerals and supplements.
OQ Chemicals is a global producer and merchant of oxo chemicals.
Lead Edge Capital explains how tariffs and the stock market turmoil are affecting dealmaking.
LDC portfolio company RDi has completed the acquisition of Inicio Health, a UK-based clinically led healthcare company.
How are the tariffs affecting dealmaking in the sectors you invest in? How are they affecting deals already in the works? How are they affecting your portfolio companies? What strategies are you deploying to handle them? What targets have become less attractive, what targets have become more attractive?